'We're ripe': Cygnal draws the curtain on Flagship's latest bet on exoneural biology — and $65M in cash 10.08.2019 Endpoints
AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics, Oct. 26-30, 2019 10.28.2019 Exhibitor